Literature DB >> 12542905

Some practical aspects of providing a diagnostic service for respiratory chain defects.

A J M Janssen1, J A M Smeitink, L P van den Heuvel.   

Abstract

The oxidative phosphorylation system (OXPHOS) is organized into five multi-protein complexes, comprising four complexes (I-IV) of the respiratory chain and ATP synthase (complex V). OXPHOS has a vital role in cellular energy metabolism and ATP production. Enzyme analysis of individual OXPHOS complexes in a skeletal muscle biopsy remains the mainstay of the diagnostic process for patients suspected of mitochondrial cytopathy. Practical guidelines are presented to provide optimal conditions for performance of laboratory investigations and a reliable diagnosis. A fresh muscle biopsy is preferable to a frozen muscle sample because the overall capacity of the OXPHOS system can be measured in a fresh biopsy. In about 25% of patients referred for muscle biopsy to our centre, reduced substrate oxidation rates and ATP+creatine phosphate production rates were found without any defect in complexes I-V and the pyruvate dehydrogenase complex. Investigation of frozen muscle biopsy alone may lead to false-negative diagnoses in many patients. In some patients, it is necessary to investigate fibroblasts for prospective diagnostic purposes. An exact diagnosis of respiratory chain defects is a prerequisite for rational therapy and genetic counselling. Provided guidelines for specimen collection are followed, there are now reliable methods for identifying respiratory chain defects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542905     DOI: 10.1258/000456303321016114

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  21 in total

1.  Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy.

Authors:  Paulien Smits; Ann Saada; Saskia B Wortmann; Angelien J Heister; Maaike Brink; Rolph Pfundt; Chaya Miller; Dorothea Haas; Ralph Hantschmann; Richard J T Rodenburg; Jan A M Smeitink; Lambert P van den Heuvel
Journal:  Eur J Hum Genet       Date:  2010-12-29       Impact factor: 4.246

2.  31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy.

Authors:  Tina Dysgaard Jeppesen; Bjørn Quistorff; Flemming Wibrand; John Vissing
Journal:  J Neurol       Date:  2007-02-04       Impact factor: 4.849

3.  NDUFA2 complex I mutation leads to Leigh disease.

Authors:  Saskia J G Hoefs; Cindy E J Dieteren; Felix Distelmaier; Rolf J R J Janssen; Andrea Epplen; Herman G P Swarts; Marleen Forkink; Richard J Rodenburg; Leo G Nijtmans; Peter H Willems; Jan A M Smeitink; Lambert P van den Heuvel
Journal:  Am J Hum Genet       Date:  2008-06       Impact factor: 11.025

4.  A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy.

Authors:  An I Jonckheere; Marije Hogeveen; Leo Nijtmans; Mariel van den Brand; Antoon Janssen; Heleen Diepstra; Frans van den Brandt; Bert van den Heuvel; Frans Hol; Tom Hofste; Livia Kapusta; U Dillmann; M Shamdeen; J Smeitink; J Smeitink; Richard Rodenburg
Journal:  BMJ Case Rep       Date:  2009-01-23

5.  C2orf69 mutations disrupt mitochondrial function and cause a multisystem human disorder with recurring autoinflammation.

Authors:  Eva Lausberg; Sebastian Gießelmann; Joseph P Dewulf; Elsa Wiame; Anja Holz; Ramona Salvarinova; Clara D van Karnebeek; Patricia Klemm; Kim Ohl; Michael Mull; Till Braunschweig; Joachim Weis; Clemens J Sommer; Stephanie Demuth; Claudia Haase; Claudia Stollbrink-Peschgens; François-Guillaume Debray; Cecile Libioulle; Daniela Choukair; Prasad T Oommen; Arndt Borkhardt; Harald Surowy; Dagmar Wieczorek; Norbert Wagner; Robert Meyer; Thomas Eggermann; Matthias Begemann; Emile Van Schaftingen; Martin Häusler; Klaus Tenbrock; Lambert van den Heuvel; Miriam Elbracht; Ingo Kurth; Florian Kraft
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

6.  SDHA mutations causing a multisystem mitochondrial disease: novel mutations and genetic overlap with hereditary tumors.

Authors:  G Herma Renkema; Saskia B Wortmann; Roel J Smeets; Hanka Venselaar; Marion Antoine; Gepke Visser; Tawfeg Ben-Omran; Lambert P van den Heuvel; Henri J L M Timmers; Jan A Smeitink; Richard J T Rodenburg
Journal:  Eur J Hum Genet       Date:  2014-04-30       Impact factor: 4.246

7.  Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs.

Authors:  Jan A M Smeitink; Orly Elpeleg; Hana Antonicka; Heleen Diepstra; Ann Saada; Paulien Smits; Florin Sasarman; Gert Vriend; Jasmine Jacob-Hirsch; Avraham Shaag; Gideon Rechavi; Brigitte Welling; Jurgen Horst; Richard J Rodenburg; Bert van den Heuvel; Eric A Shoubridge
Journal:  Am J Hum Genet       Date:  2006-09-15       Impact factor: 11.025

8.  Mutation in subdomain G' of mitochondrial elongation factor G1 is associated with combined OXPHOS deficiency in fibroblasts but not in muscle.

Authors:  Paulien Smits; Hana Antonicka; Peter M van Hasselt; Woranontee Weraarpachai; Wolfram Haller; Marieke Schreurs; Hanka Venselaar; Richard J Rodenburg; Jan A Smeitink; Lambert P van den Heuvel
Journal:  Eur J Hum Genet       Date:  2010-12-01       Impact factor: 4.246

Review 9.  Biochemical diagnosis of mitochondrial disorders.

Authors:  Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

10.  Normal biochemical analysis of the oxidative phosphorylation (OXPHOS) system in a child with POLG mutations: a cautionary note.

Authors:  M C de Vries; R J Rodenburg; E Morava; M Lammens; L P W van den Heuvel; G Christoph Korenke; J A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.